Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Hyperbilirubinemia Predisposes to the Incidence of Nosocomial Infection in Egyptian Patients with Cirrhosis: A cohort Study

View through CrossRef
Background: nosocomial infection (NIs) is a major challenge in healthcare facilities and has been associated with prolonged hospital stay as well as increased morbidity and mortality. Aims: This research aimed to estimate the impact of acute decompensation (AD) consequences on the successive risk of nosocomial infections (NIs) and the go after outcome. Methods: A total of 250 hospitalized cirrhotic patients with decompensation were included in the study. Different decompensation events and after-effects in patients with or without NIs were compared. The logistic regression and Cox proportional hazards models were designed for NIs development and mortality at 28 days, respectively. Results: During hospitalization, 22.4 % of patients developed NIs. Remarkably, a higher percentage of patients with NIs had jaundice (42.9% vs. 26.8 %; p= 0.06 at admission compared to patients without NIs, whilst a lower percentage had gastrointestinal hemorrhage (14.3 vs. 33.5%; p=0.017+). Multivariate analysis revealed that jaundice was independently linked with the development of NIs (OR, 0.474; 95% CI: 0.24–0.92). The 28-day mortality rates of patients with NIs were significantly higher than those without NIs (21.4 vs. 9%; p = 0.014). According to the Cox proportional hazards model, jaundice stayed an independent risk factor for 28-day death (HR,8.38; 95% CI: 3.58–19.62). Conclusion: Different decompensation events have different impact on the incidence of Nosocomial infections. Jaundice is independently associated with occurrence of NIs and increased 28-day mortality. Therefore, prophylaxis measures are recommended to benefit this specific subsection of patients. Keywords Decompensation, nosocomial infections, jaundice, mortality, hospitalization
Title: Hyperbilirubinemia Predisposes to the Incidence of Nosocomial Infection in Egyptian Patients with Cirrhosis: A cohort Study
Description:
Background: nosocomial infection (NIs) is a major challenge in healthcare facilities and has been associated with prolonged hospital stay as well as increased morbidity and mortality.
Aims: This research aimed to estimate the impact of acute decompensation (AD) consequences on the successive risk of nosocomial infections (NIs) and the go after outcome.
Methods: A total of 250 hospitalized cirrhotic patients with decompensation were included in the study.
Different decompensation events and after-effects in patients with or without NIs were compared.
The logistic regression and Cox proportional hazards models were designed for NIs development and mortality at 28 days, respectively.
Results: During hospitalization, 22.
4 % of patients developed NIs.
Remarkably, a higher percentage of patients with NIs had jaundice (42.
9% vs.
26.
8 %; p= 0.
06 at admission compared to patients without NIs, whilst a lower percentage had gastrointestinal hemorrhage (14.
3 vs.
33.
5%; p=0.
017+).
Multivariate analysis revealed that jaundice was independently linked with the development of NIs (OR, 0.
474; 95% CI: 0.
24–0.
92).
The 28-day mortality rates of patients with NIs were significantly higher than those without NIs (21.
4 vs.
9%; p = 0.
014).
According to the Cox proportional hazards model, jaundice stayed an independent risk factor for 28-day death (HR,8.
38; 95% CI: 3.
58–19.
62).
Conclusion: Different decompensation events have different impact on the incidence of Nosocomial infections.
Jaundice is independently associated with occurrence of NIs and increased 28-day mortality.
Therefore, prophylaxis measures are recommended to benefit this specific subsection of patients.
Keywords Decompensation, nosocomial infections, jaundice, mortality, hospitalization.

Related Results

Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Does Gender Affect Levels of Hyperbilirubinemia in Term Neonates
Does Gender Affect Levels of Hyperbilirubinemia in Term Neonates
Introduction: Hyperbilirubinemia is a common & in most1cases, benign problem in1first month of1life which is often1physiologic & intervention is not1usually1necessary. In t...
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
Abstract Cirrhosis is a leading cause of death among patients infected with human immunodeficiency virus (HIV). We sought to determine risk factors for and time trends ...
Echocardiographic features, mortality, and adrenal function in patients with cirrhosis and septic shock
Echocardiographic features, mortality, and adrenal function in patients with cirrhosis and septic shock
Objectives: Cirrhosis of the liver is associated with an increased susceptibility to bacterial infections capable of causing septic shock and with a basal hyperdynamic circulatory...
Hyperbilirubinemia and associated factors among neonates admitted to neonatal care unit in Jimma Medical Center
Hyperbilirubinemia and associated factors among neonates admitted to neonatal care unit in Jimma Medical Center
Abstract Background: Neonatal hyperbilirubinemia is a widespread and significant clinical problem among neonates worldwide. Globally, every year about 1.1 million babies de...
Evolutive Aspects Of Patients With Cirrhosis After Harvoni Therapy
Evolutive Aspects Of Patients With Cirrhosis After Harvoni Therapy
Introduction: Cirrhosis, is a final pathway of chronic liver diseases. In recent years, Direct-Acting Antiviral Agents (DAAs) gained a leading role in the treatment of chronic hepa...

Back to Top